ArticleTherapeutic advances in neurological disorders2026
Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective study.
Juan Luis Chico-Garcia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.